Reading the Winds: The SEC’s Cybersecurity Program After SolarWinds
The SolarWinds decision has wide implications for the SEC’s cybersecurity program going forward, with lessons playing out.
Recent Developments in False Claims Act Constitutionality
The Eleventh Circuit has an opportunity to ensure that one of the main tools in the government’s fight against fraud is protected.
A Brief History of False Claims Act Constitutionality
The use of whistleblowers by the government to fight fraud in the United States dates all the way back to the 1600 Colonial Era.
The Middle District of Florida Court Finds the Qui Tam Provision of the False Claims Act Unconstitutional because a Relator is an “Officer” of the United States
We are only recovering a fraction of the billions of dollars being lost to fraud. Whistleblowers are stepping up if the government has the resources to run with their cases.
More Resources Are Needed in the Fight on Fraud
We are only recovering a fraction of the billions of dollars being lost to fraud. Whistleblowers are stepping up if the government has the resources to run with their cases.
An Ounce of Prevention is Worth Billions for a Cure
With $10.2 billion worth of critical function services, opportunities for fraud are everywhere.
Which U.S. Attorneys’ Offices Brought in the Highest Recoveries in the Past Five Years?
In today's Fraud By The Numbers, we're diving into the various U.S. Attorney Offices and how much has been recovered.
DOJ's Civil Cyber-Fraud Initiative: A Milestone in Cybersecurity Enforcement
After launching three years ago, the Civil Cyber-Fraud Initiative continues to rack up wins -- becoming a critical tool to address and deter cybersecurity lapses.
The Government Spends Much Less on Fraud Cases than Big Companies Spend Defending Them
One U.S. Chamber of Commerce-funded survey of Fortune 200 companies found that the average total cost of outside litigation was $115 million per respondent in 2008.
Pill Talk: Negotiating, Lobbying, and Inflating Drug Prices
From 2000 to 2020, the government increased its spending on prescription drugs by 91 percent, now it's trying to rein in costs.
